NORTH CHICAGO (dpa-AFX) - Abbott (ABT) said it has received U.S. Food and Drug Administration clearance to use its iFS Advanced Femtosecond Laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery. The iFS Laser is currently used to create LASIK flaps and other corneal incisions in the eye and is the fifth generation of IntraLase technology, which has been used in over 5 million procedures worldwide.
About 3 million patients undergo cataract surgery each year in the U.S. On obtaining this new clearance, the iFS Laser now gives surgeons the ability to make precise, bladeless arcuate incisions during surgery and customize the incision for each individual patient, the company added.
The study data support that the iFS Femtosecond laser creates arcuate incisions safely and effectively as prescribed by the physician, and complies with applicable safety standards, while this new use of Abbott's iFS Femtosecond laser is available now in the U.S.
Copyright RTT News/dpa-AFX